IN8bio Inc (NASDAQ:INAB) does about 2.61M shares in volume on a normal day but saw 16321740 shares change hands in the recent trading day. The company now has a market cap of 12.14M USD. Its current market price is $0.13, marking a decrease of -9.78% compared to the previous close of $0.15. The 52 week high reached by this stock is $1.74 whilst the lowest price level in 52 weeks is $0.11.
The consensus objective for the share price is $3.59, suggesting that the stock has a potential upside of 96.38% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 18, 2024 when Laidlaw initiated the stock to “Buy” and issued a price target of $7.50.
The current price level is -8.77%, -18.39%, and -51.51% away from its SMA20, SMA50, and SMA200 respectively, with the INAB price moving above the 50-day SMA on current market day. IN8bio Inc (INAB) stock is down -7.73% over the week and -21.31% over the past month. Its price is -48.02% year-to-date and -86.89% over the past year.
To reach the target analysts have set, the stock logically needs to grow 96.38 percent from here.
Outstanding shares total 81.26M with insiders holding 4.89% of the shares and institutional holders owning 23.88% of the company’s common stock. The company has a return on investment of -162.16% and return on equity of -174.66%. The beta has a value of 0.18. Price to book ratio is 0.78.
